¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inclusion compound"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inclusion cast
    Æ÷ÇÔü¿øÁÖ
  • inclusion cyst
    Æ÷ÇÔ¹°³¶, ºÀÀÔ³¶
  • inclusion disease
    Æ÷ÇÔüº´, ºÀÀÔüº´
  • inclusion/exclusion criteria
    Æ÷ÇÔÁ¦¿Ü±âÁØ
  • intracellular inclusion body
    ¼¼Æ÷³»Æ÷ÇÔü, ¼¼Æ÷³»ºÀÀÔü
  • intranuclear inclusion body
    ÇÙÆ÷ÇÔü, ÇÙ³»ºÀÀÔü
  • viral inclusion
    ¹ÙÀÌ·¯½ºÆ÷ÇÔ¹°
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
  • closed-chain compound
    ´ÝÈù»ç½½È­ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inclusion body fibromatosis
    Æ÷ÇÔü¼¶À¯Á¾Áõ
  • hyaline inclusion
    À¯¸®ÁúÆ÷ÇÔ¹°, À¯¸®ÁúºÀÀÔü
  • inclusion
    Æ÷ÇÔ¹°
  • viral inclusion
    ¹ÙÀÌ·¯½ºÆ÷ÇÔ¹°
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • compound astigmatism
    º¹ÇÕ³­½Ã
  • compound
    º¹Àâ, º¹ÇÕ, È­ÇÕ¹°
  • chain compound
    »ç½½È­ÇÕ¹°
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • addition compound
    ÷°¡È­ÇÕ¹°(ôÕÊ¥ ûùùêÚª).
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°.
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°.
  • amino compound
    ¾Æ¹Ì³ëÈ­ÇÕ¹°(¡­ûùùêÚª).
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°(¡­ûùùêÚª).
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦.
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°.
  • heme compound
    ÇðÈ­ÇÕ¹°
  • heterocyclic compound
    ÇìÅ×·Î°í¸®È­ÇÕ¹°, ÀÌÁ¾¿øÀÚ°í¸®È­ÇÕ¹°.
  • heteropolar compound
    ÀÌ(¼º)±ØÈ­ÇÕ¹°(ì¶àõпûùùêÚª).
  • homeopolar compound
    µ¿±ØÈ­ÇÕ¹°.
  • homocyclic compound
    µ¿¼Òȯ½ÄÈ­ÇÕ¹°.
  • homopolar compound
    µ¿±ØÈ­ÇÕ¹°(ÔÒпûùùêÚª).
  • impression compound
    Àλó¿ë ÄÄÆÄ¿îµå.
  • inorganic compound
    ¹«±âÈ­ÇÕ¹°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • epidermal inclusion cyst
    Ç¥ÇÇ ºÀÀÔ ³¶Á¾(¡­Üæìý Ò¥ðþ)
  • epithelial inclusion
    »óÇǺÀÀÔ.
  • fetal inclusion
    žƺÀÀÔ(¡­Üæìý).
  • fetal inclusion
    ºÀÀÔžÆ
  • hyaline inclusion
    À¯¸®Áú ºÀÀÔ(ü)
  • inclusion blennorrhea
    ºÀÀÔü³ó·ç¾È.
  • inclusion blenorrhea
  • inclusion body
    ºÀÀÔü
  • inclusion body disease
    ºÀÀÔüº´.
  • inclusion body fibromatosis
    ºÀÀÔü ¼¶À¯Á¾Áõ
  • inclusion body myositis
    ºÀÀÔü ±Ù¿°(¡­ÐÉæú)
  • inclusion body, cytoplasmic
    ¼¼Æ÷Áú³» ºÀÀÔü
  • inclusion body, intracytoplasmic
    ¼¼Æ÷³»ºÀÀÔü
  • inclusion cast
    ºÀÀÔü¿øÁÖ
  • inclusion conjunctivities
    ºÀÀÔü °á¸·¿°(¡­Ì¿Ø¯æú)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • labeled compound
    Ç¥ÁöÈ­ÇÕ¹°(øöò½ûùùêÚª)
  • low-energy compound
    Àú(î¸)¿¡³ÊÁöÈ­ÇÕ¹°(ûùùêÚª)
  • meso compound
    ¸Þ¼ÒÈ­ÇÕ¹°(ûùùêÚª)
  • nodal compound
    ¿ËÀÌ È­ÇÕ¹°(ûùùêÚª)
  • prochiral compound
    ۶ö Àü±¸È­ÇÕ¹°(îñÏÌûùùêÚª)
  • quaternary ammonium compound
    »çÂ÷(ÞÌó­) ¾Ï¸ð´Ï¾ÆÈ­ÇÕ¹°(ûùùêÚª).
  • Reichstein's compound
    ¶óÀÌÅ©½ºÅ¸ÀÎ È­ÇÕ¹°(ûùùêÚª)
  • van der Waals compound
    ¹Ý µ§ ¹ß½º È­ÇÕ¹°(ûùùêÚª)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CID cellular immunodeficiency; charge injection device; chick infective dose; combined immunodeficiency ...
CMID cytomegalic inclusion disease
IB idiopathic blepharospasm; immune body; inclusion body; index of body build; infectious bronchitis; I...
IBM inclusion body myositis
ID identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OP organophosphorus compound
OLC Ouabainlike compound
OPIDN organophosphorous compound-induced delayed neurotoxicity
GPIC Guinea pig inclusion conjunctivitis
IBH Inclusion Body Hepatitis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • compound action potential
    º¹ÇÕ È°µ¿ Àü¾Ð
  • compound anchorage
    º¹ÇÕ °íÁ¤
    µÎ °³ ȤÀº ±× ÀÌ»óÀÇ Ä¡¾Æ·ÎºÎÅÍ ÀúÇ×À» ¹Þ´Â ±³Á¤ °íÁ¤.
  • compound cavity
    º¹ÇÕ ¿Íµ¿
    óġµÈ »óÅ¿¡¼­ Ä¡¾ÆÀÇ 2¸éÀÌ Ä§½ÀµÈ ¿ì½Ä º´¼Ò.
  • compound composite odontoma
    º¹ÇÕ¼º Ä¡¾ÆÁ¾, ÁýÇÕ¼º Ä¡¾ÆÁ¾
  • compound dislocation
    º¹Àâ Å»±¸
  • compound gland
    º¹ÇÕ »ù, º¹ÇÕ¼±
    ºÐºñ °üÀÌ °¡Áö¸¦ ³½´Ù. ºÐºñ ´ÜÀ§´Â È¥ÇÕÇüÀ¸·Î, °ü»ó Æ÷»ó »ùÀ̶ó´Â ¿ë¾î°¡ »ç¿ëµÈ´Ù.
  • compound nevus
    º¹ÇÕ¼º ¸ð¹Ý, º¹ÇÕ ¸ð¹Ý
  • compound S
    º¹ÇÕü S
  • compound scan motion
    º¹ÇÕ ½ºÄµ ¿îµ¿
  • compound specificity
    È­ÇÕ¹° ƯÀ̼º
  • hydrated compound
    ¼öÈ­ È­ÇÕ¹°
  • impression compound
    Àλó¿ë ÄÞÆÄ¿îµå
    Àλó¿ë°ú Æ®·¹ÀÌ¿ëÀÌ ÀÖ°í, õ¿¬ ¼öÁö, ÇÕ¼º ¼öÁö µîÀ¸·Î µÇ¾î ¿­ °¡¼Ò¼ºÀ» °®´Â ÀλóÀç.
  • inorganic compound
    ¹«±â È­ÇÕ¹°
    ź¼Ò¸¦ Æ÷ÇÔÇÏÁö ¾Ê´Â È­ÇÕ¹°.
  • intermetallic compound
    ±Ý¼Ó°£ È­ÇÕ¹°
    ¼ººÐ ¿ø¼Ò°¡ °£´ÜÇÑ Á¤¼öºñ·Î °áÇÕÇϰí ÀÖ´Â ÇÕ±Ý.
  • modeling compound impression
    ¿¬¼ºÀç Àλó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
inclusion body encephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
inclusion body myositis <radiology> Common form of inflamatory myopathy, most common in the elderly, equal sex incidence, sporadic idiopathic disease (very rarely familial), misdiagnosed as steroid-resistant polymyositis symptoms, presents as a painless slowly progressive proximal myopathy, may cause dysphagia, mild to moderate muscle wasting diagnosis, serum creatine kinase levels usually normal or only slightly elevated, EMG may show non-specific myopathic features, diagnosis on muscle biopsy, inclusion bodies seen in rimmed vacuoles in skeletal muscle fibres treatment, steroids and immunosuppression generally ineffective, rare patients reported who have made a response to treatment pathogenesis, unknown, ubiquitin, prion protein, tau protein found in inclusions, abnormal mitchondria seen in some case
(12 Dec 1998)
inclusion body rhinitis A respiratory disease of pigs caused by the cytomegalovirus porcine herpesvirus 2 and characterised by rhinitis and conjunctivitis in young pigs.
(05 Mar 2000)
inclusion cell i cell
inclusion cell disease <biochemistry> Mucolipidosis of early onset and with severe symptoms like those in Hurler's syndrome but with normal urinary mucopolysaccharides, vacuolated lymphocytes, and inclusion bodies in cultured fibroblasts (I-cells).
The lysosomes lack hydrolases but high concentrations of lysosomal enzymes are found in the extracellular fluids such as serum, spinal fluid, and urine.
It is associated with a deficiency of N-acetylglucosaminyl-1-phosphotransferase. The gene defect responsible probably prevents the addition of the lysosome recognition marker mannose 6 phosphate) to these enzymes so that they are not directed into the lysosomes but are released.
Inheritance: autosomal recessive.
Synonym: I-cell disease, inclusion cell disease.
(12 Jul 2000)
inclusion conjunctivitis A follicular conjunctivitis caused by Chlamydia trachomatis.
(05 Mar 2000)
inclusion conjunctivitis viruses Former name for Chlamydia trachomatis.
(05 Mar 2000)
inclusion cyst Intradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules.
(12 Dec 1998)
inclusion dermoid A collection of cancerous cells which form cysts that contain one or more of the three primary embryonic germ layers: skin, hair or teeth.
(27 Sep 1997)
epidermoid inclusion cyst <radiology> Well-circumscribed radiolucent lesion showing a thin cortical margin that may not be visible in its entirety, frequently in the terminal phalanx, history of penetrating trauma is often elicited Differential diagnosis: ABC, enchondroma
(12 Dec 1998)
foetal inclusion Unequal conjoined twins in which the incompletely developed parasite is wholly enclosed in the autosite.
(05 Mar 2000)
acetone compound <biochemistry> Any of the three compounds created by acetyl coenzyme A (acetoacetate, hydroxybutyrate, and acetone) which are water-soluble cellular fuels normally exported by the liver.
They can build up in the blood and body tissues because of starvation, untreated diabetes mellitus, or other disorders that interfere with carbohydrate metabolism. The body rids itself of ketones mainly through urine, but it rids itself of acetone through the lungs, which gives the breath a characteristic fruity odour. If ketones build up in the body long enough, they cause serious illness and coma (see ketoacidosis.)
(09 Oct 1997)
acyclic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
addition compound Strictly, a complex of two or more complete molecules in which each preserves its fundamental structure and no covalent bonds are made or broken (e.g., hydrates of salts, adducts), loosely, association of acids with basic organic compound's (e.g., amines with HCl), more loosely, addition of two molecules without loss of any atom, but forming new covalent bonds (e.g., CH2==CH2 + Br2 &rarr; BrCH2-CH2Br).
(05 Mar 2000)
aliphatic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • compound leaf
    °ãÀÙ;º¹¿±
  • compound microscope
    º¹ÇÕÇö¹Ì°æ
  • compound number
    Á¦µî¼ö(µÑÀÌ»óÀÇ ´ÜÀ§·Î Ç¥½ÃµÇ´Â ¼ö)
  • compound personal pronoun
    º¹ÇÕ ÀÎĪ ´ë¸í»ç(ÀÎĪ ´ë¸í»ç µÚ¿¡ -self°¡ ºÙÀº °Í)
  • compound relative
    º¹ÇÕ°ü°è»ç
  • compound sentence
    Áß¹®(ÀýÀ» and,butµî µîÀ§ Á¢¼Ó»ç·Î ÀÌÀº ¹®Àå)
  • compound word
    º¹ÇÕ¾î;ÇÕ¼º¾î
  • compound-complex sentence
    Áߺ¹¹®(Á¾¼ÓÀýÀ» ÇϳªÀÌ»ó °¡Áø Áß¹®)
  • interstitia compound
    È­ ħÀÔÇüÈ­ÇÕ¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á